Jul 19, 2021 15:42 Source: BSE
IOL Chemicals and Pharmaceuticals - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of analyst / investor Meet
Jul 19, 2021 15:31 Source: BSE
IOL Chemicals and Pharmaceuticals - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of duplicate share certificate
Jul 19, 2021 15:29 Source: BSE
IOL Chemicals and Pharmaceuticals - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in newspapers regarding loss of Share Certificates
Jul 10, 2021 10:38 Source: BSE
IOL Chemicals and Pharmaceuticals - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June 2021
Jul 10, 2021 9:26 Source: BSE
IOL Chemicals and Pharmaceuticals - Statement Of Investor Complaints For The Quarter Ended June 2021
| No.of Investor complaints pending at the beginning of the quarter || No.of Investor complaints received during the quarter|| No.of Investor complaints disposed of during the quarter || No.of Investor complaints unresolved at the end of the quarter |
| Name of the Signatory || :- ||Abhay Raj Singh|
|Designation || :- ||Company Secretary and Compliance Officer|
Jul 08, 2021 17:59 Source: BSE
IOL Chemicals and Pharmaceuticals - Shareholding for the Period Ended June 30, 2021
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here
Jul 05, 2021 17:19 Source: BSE
IOL Chemicals and Pharmaceuticals - Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30 and any other provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that CARE Ratings Limited vide its letter dated 01st July 2021 received by Company on 05th July 2021, has upgraded the Credit Rating by one notch for the banking facilities availed by the Company.
Jul 05, 2021 13:49 Source: BSE
IOL Chemicals and Pharmaceuticals - Increase In Volume
With reference to your mail, reference no. L/SURV/ONL/PV/RS/2021-2022/186 dated 05.07.2021, we wish to submit that there is no such announcement or price sensitive information, which is pending to be intimated by the Company to the Stock Exchange that have a bearing on the operation /performance of the Company. We would like to further inform and clarify that all the information furnished by the Company is · in public domain and Company will keep the Stock Exchanges duly informed of all the price sensitive information(s) in compliance with SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
Jul 05, 2021 12:22 Source: BSE
IOL Chemicals and Pharmaceuticals - Clarification sought from IOL Chemicals & Pharmaceuticals Ltd
The Exchange has sought clarification from IOL Chemicals & Pharmaceuticals Ltd on July 5, 2021, with reference to Movement in Volume.The reply is awaited.
Jun 29, 2021 15:08 Source: BSE
IOL Chemicals and Pharmaceuticals - Closure of Trading Window
Pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's 'Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons' the Trading Window for dealing in the securities of the Company, shall remain closed for all the designated persons and their immediate relatives from 01st July 2021 till the expiry of 48 hours after the declaration of financial results for quarter ended 30th June 2021 are made public. During the closure of Trading Window, Insiders are also advised not to deal in the shares of the Company.